Search Results - "ROSENCHER, Lise"
-
1
Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic
Published in Bulletin du cancer (01-04-2012)Get full text
Journal Article -
2
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort
Published in Clinical and experimental allergy (01-07-2020)“…Background Dupilumab is a monoclonal anti‐IL‐4Rα antibody developed for the treatment of severe asthma (SA). An early access programme for dupilumab was opened…”
Get full text
Journal Article -
3
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
Published in The lancet respiratory medicine (01-07-2020)“…Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool,…”
Get full text
Journal Article -
4
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients
Published in Respiratory medicine and research (01-11-2024)Get full text
Journal Article -
5
Routine administration of a single dose of cisplatin≥75mg/m2 after short hydration in an outpatient lung-cancer clinic
Published in Bulletin du cancer (01-04-2012)“…Cisplatin is a pivotal drug in combined chemotherapy for non-small cell and small-cell lung cancers (NSCLC or SCLC), but its renal toxicity limits its use…”
Get full text
Journal Article -
6
Management of acute asthma exacerbations by general practitioners: a cross-sectional observational survey
Published in British journal of general practice (01-10-2004)“…General practitioners (GPs) have a central place in the management of asthma, particularly in the context of acute exacerbations. To evaluate the management of…”
Get full text
Journal Article -
7
Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic
Published in Bulletin du cancer (01-04-2012)“…Cisplatin is a pivotal drug in combined chemotherapy for non-small cell and small-cell lung cancers (NSCLC or SCLC), but its renal toxicity limits its use…”
Get more information
Journal Article